NDAQ:GCTK - Post Discussion
GlucoTrack Inc
> Glucotrack's Innovative Blood Glucose Monitoring Concept Res
Post by
whytestocks on Aug 15, 2024 12:01pm
Glucotrack's Innovative Blood Glucose Monitoring Concept Res
BREAKING NEWS: $GCTK Glucotrack's Innovative Blood Glucose Monitoring Concept Resonates with Patients with Diabetes, According to New Survey Presented at Association of Diabetes Care and Education Specialists (ADCES) 2024 Annual ConferenceGlucotrack ADCES poster highlights over 50% of surveyed diabetes patients are open to new Continuous Blood Glucose Monitor concept Rutherford, NJ, Aug. 15, 2024 (GLOBE NEWSWIRE) -- Glucotrack, Inc. (Nasdaq: GCTK) (“Glucotrack” or the “Company”), a medical technol...
GCTK - Glucotrack's Innovative Blood Glucose Monitoring Concept Resonates with Patients with Diabetes, According to New Survey Presented at Association of Diabetes Care and Education Specialists (ADCES) 2024 Annual Conference
Be the first to comment on this post